Thomas James Belbin

Dr. Thomas James Belbin

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
RLRoberto A. Lleras
Roberto A. Lleras
LALeslie R. Adrien
Leslie R. Adrien
RSRichard Vance Smith
Richard Vance Smith
BBBenjamin Brown
Benjamin Brown
NJNaheed Jivraj
Naheed Jivraj
TBThomas James Belbin
Thomas James Belbin

1 January 2023 in Journal of Otolaryngology - Head & Neck Surgery
Verified
Journal Article
Open access
PPPatrick Pearson
Patrick Pearson
KSKendra Smith
Kendra Smith
NSNilita Sood
Nilita Sood
ECElizabeth Chia
Elizabeth Chia
AFAlicia Follett
Alicia Follett
TBThomas James Belbin
Thomas James Belbin
Background: Krüppel-type zinc finger protein genes located on chromosome 19q13 are aberrantly hypermethylated with high frequency in all anatomic sub-sites of head and neck cancers as well as other epithelial tumours resulting in decreased expression. Methods: We examined prognostic significance of ZNF154 and ZNF132 expression and DNA methylation in independent patient cohort of about 500 head and neck cancer patients in the Cancer Genome Atlas (TCGA). We also overexpressed these genes in HEK-293 cells, as well as the oral cancer cell line UM-SCC-1. Results: In 20 patients from the TCGA cohort of HNSCC patients where ZNF154 and ZNF132 DNA methylation and RNA expression could be compared in tumor and adjacent normal tissue, there was increased DNA methylation and decreased expression of both ZNF154 and ZNF132 in primary tumours. Low ZNF154 and low ZNF132 expression were associated with shorter overall survival in both head and neck squamous cell carcinoma (HNSCC) and lung adenocarcinoma (LUAC patients). While expression of these proteins in HEK-293 cells produced full-length protein, only truncated copies could be expressed in head and neck cancer cells (UM-SCC-1). The truncated version of ZNF154 protein increased doubling time and reduced cell migration in UM-SCC-1 cancer cells. Conclusions: Both ZNF132 and ZNF154 represent novel clinically significant biomarkers in head and neck cancer with potential tumour suppressive properties. Future studies will address the underlying molecular mechanisms by which ZNF154 expression in HNSCC contributes to the control of cell growth and migration. Graphical

1 November 2015 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Open access
DMD.J. Mark
D.J. Mark
RKRafi Kabarriti
Rafi Kabarriti
PBP.O. Broin
P.O. Broin
TBThomas James Belbin
Thomas James Belbin
Thomas M. HarrisThomas M. Harris
Thomas M. Harris
MGM.K. Garg
M.K. Garg

29 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
KSKendra Smith
Kendra Smith
RZRUFAI UMAR ZUBAIR
RUFAI UMAR ZUBAIR
RSRichard Vance Smith
Richard Vance Smith
SAStelby Augustine
Stelby Augustine
NSNicolas F. Schlecht
Nicolas F. Schlecht
TBThomas James Belbin
Thomas James Belbin
Background: Novel ZNF genes, such as ZNF671, that are located on chromosome 19q13 are known to be hypermethylated at a high frequency in HNSCC as well as in other epithelial solid tumors. Their function is largely unknown. Results: Here, we show that ZNF671 is epigenetically silenced in HNSCC primary tumors compared to matched adjacent normal tissue. Moreover, low expression of ZNF671 is significantly associated with decreased survival in HNSCC patients. Over-expression of ZNF671 in UM-SCC-1 oral cancer cells resulted in a significant reduction in tumor cell mobility and invasion compared to the empty-vector control cells. Transcriptomic analysis showed that ZNF671 re-expression resulted in a significant decrease in the expression of a major oncogenic long non-coding RNA LINC00665. Conclusions: Together, these results suggest that epigenetic silencing of ZNF671 may activate multiple oncogenic signaling pathways via the resulting up-regulation of LINC00665.

22 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
RZRUFAI UMAR ZUBAIR
RUFAI UMAR ZUBAIR
KSKendra Smith
Kendra Smith
RSRichard Vance Smith
Richard Vance Smith
SAStelby Augustine
Stelby Augustine
NSNicolas F. Schlecht
Nicolas F. Schlecht
TBThomas James Belbin
Thomas James Belbin
Novel ZNF proteins such as ZNF671 that are located on chromosome 19q13 are known to be hypermethylated at a high frequency in HNSCC as well as in other epithelial solid tumors. Their function is largely unknown. Here, we show that ZNF671 is epigenetically silenced in HNSCC primary tumors compared to matched adjacent normal tissue. Moreover, low expression of ZNF671 is significantly associated with decreased survival in HNSCC patients. Over-expression of ZNF671 in UM-SCC-1 oral cancer cells resulted in a significant reduction in tumor cell mobility and invasion compared to the empty-vector control cells. Transcriptomic analysis showed that ZNF671 re-expression resulted in a significant decrease in the expression of a major oncogenic long non-coding RNA LINC00665. Together, these results suggest that epigenetic silencing of ZNF671 may activate multiple oncogenic signaling pathways via the resulting up-regulation of LINC00665.